textabstractBackground The time by which prostate-specific antigen (PSA) screening advances prostate cancer diagnosis, called the lead time, has been reported by several studies, but results have varied widely, with mean lead times ranging from 3 to 12 years. A quantity that is closely linked with the lead time is the overdiagnosis frequency, which is the fraction of screen-detected cancers that would not have been diagnosed in the absence of screening. Reported overdiagnosis estimates have also been variable, ranging from 25% to greater than 80% of screen-detected cancers.Methods We used three independently developed mathematical models of prostate cancer progression and detection that were calibrated to incidence data from the Surveillanc...
Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detectio...
tate cancer is considered a major potential drawback of prostate-specific antigen (PSA) screening. Q...
Background: Lead time (LT) is of key importance in early detection of cancer, but cannot be directly...
Background The time by which prostate-specific antigen (PSA) screening advances prostate cancer diag...
Background The time by which prostate-specific antigen (PSA) screening advances prostate cancer diag...
textabstractBACKGROUND: Screening for prostate cancer advances the time of diagnosis (lead tim...
Background: Screening for prostate cancer advances the time of diagnosis (lead time) and detects can...
Background: Lead-time is defined as the time by which screening advances the diagnosis compared with...
Background: Lead-time is defined as the time by which screening advances the diagnosis compared with...
Background: Screening for prostate cancer advances the time of diagnosis (lead time) and detects can...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detectio...
Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detectio...
Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detectio...
tate cancer is considered a major potential drawback of prostate-specific antigen (PSA) screening. Q...
Background: Lead time (LT) is of key importance in early detection of cancer, but cannot be directly...
Background The time by which prostate-specific antigen (PSA) screening advances prostate cancer diag...
Background The time by which prostate-specific antigen (PSA) screening advances prostate cancer diag...
textabstractBACKGROUND: Screening for prostate cancer advances the time of diagnosis (lead tim...
Background: Screening for prostate cancer advances the time of diagnosis (lead time) and detects can...
Background: Lead-time is defined as the time by which screening advances the diagnosis compared with...
Background: Lead-time is defined as the time by which screening advances the diagnosis compared with...
Background: Screening for prostate cancer advances the time of diagnosis (lead time) and detects can...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detectio...
Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detectio...
Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detectio...
tate cancer is considered a major potential drawback of prostate-specific antigen (PSA) screening. Q...
Background: Lead time (LT) is of key importance in early detection of cancer, but cannot be directly...